BenzingaOctober 12, 2026 at 1:57 AM NY15 Days Ago
BTIG Maintains Buy on DexCom, Raises Price Target to $96
BTIG analyst Ryan Zimmerman maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $90 to $96.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
